GlassScriptPhysician profile
Sharon Zhang
NPI 1598182651
$1,531.58
in general payments reported to CMS, 2019-2025
8 companies · $624 in 2025
The $624 reported for 2025 was more than what 82% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $628 · 2024: $160 · 2025: $624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,222 · Travel and Lodging: $134 · Education: $54.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.42 |
| Travel and Lodging | $134.47 |
| Education | $54.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $424.54 | 2023-2025 | Dysport |
| Spr Therapeutics, INC | $242.70 | 2025 | Sprint Pns System |
| Medtronic, INC. | $213.59 | 2023-2025 | Synchromedii, Intellis Adaptivestim |
| Merz Pharmaceuticals, LLC | $200.80 | 2023-2024 | Xeomin |
| Abbvie INC. | $178.91 | 2022-2023 | Botox |
| Mml US, INC. | $128.14 | 2025 | Reactiv8 |
| Pacira Pharmaceuticals Incorporated | $122.81 | 2023 | Zilretta |
| Novartis Pharmaceuticals Corporation | $20.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.